This announcement is a separate document:
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Lewis William
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.